Drug intelligence / Profile preview

Cy5-uPA-probe

Development stage
Preclinical
Lead developer
University of Antwerp
Modality
Small Molecules
Administration
Intravenous
01

Overview

Cy5-uPA-probe is a fluorescently labeled activity-based probe designed for the non-invasive near-infrared (NIR) imaging of active urokinase plasminogen activator (uPA) expression in vivo. Developed by researchers at the University of Antwerp, the probe is based on the irreversible, non-peptidic uPA inhibitor UAMC-00150 conjugated to a Cy5 fluorophore. It selectively and covalently binds to active uPA, a serine protease heavily implicated in extracellular matrix degradation, tumor invasion, and metastasis. Cy5-uPA-probe has been evaluated in preclinical orthotopic breast cancer mouse models (such as MDA-MB-231) to visualize uPA activity, serving as a potential diagnostic biomarker tool for breast cancer and other solid tumors.

Other names
Cy5-labeled uPA activity-based probeCy-5-labeled uPA activity-based probeCy 5-labeled uPA activity-based probeCy5-uPA activity-based probeCy-5-uPA activity-based probeCy 5-uPA activity-based probe
02

Targets

PLAU (uPA)F2 (Thrombin)

Beyond the preview

Go deeper on Cy5-uPA-probe.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cy5-uPA-probe.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call